You are here

Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort ascending
2002 R43 CA094404 PAR-01-105 MARTIN, MARK MIRARI BIOSCIENCES, INC. MICROWAVE-ENHANCED LUMINESCENCE TO DETECT GROWTH FACTORS Complete
2006 R21 CA116102 RFA-CA-06-002 TSOURKAS, ANDREW UNIVERSITY OF PENNSYLVANIA NOVEL PROBE FOR QUANTITATIVE IMAGING OF GENE EXPRESSION Complete
2008 R44 CA120619 RFA-CA-07-041 LEE, PHILIP J CELLASIC CORPORATION MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS Complete
2012 R21 CA173347 RFA-CA-12-002 GRZYBOWSKI, BARTOSZ ANDRZEJ NORTHWESTERN UNIVERSITY MICROSYSTEMS FOR TARGETING LEVY WALKS IN METASTATIC CANCER CELLS Complete
2015 R43 CA199142 PAR-13-327 ORBAI, LUCIAN CELL DATA SCIENCES, INC. RESCUING NUCLEIC ACIDS FROM FORMALIN DAMAGE IN CANCER SPECIMENS Complete
2000 R21 CA088365 PAR-99-100 TUNG, CHING-HSUAN MASSACHUSETTS GENERAL HOSPITAL IN VIVO IMAGING OF MATRIX METALLOPROTEASE Complete
2002 R21 CA094408 PAR-99-100 SOMMER, STEVE SEEV CITY OF HOPE/BECKMAN RESEARCH INSTITUTE CARBON NANOTUBES: ARTIFICAL GELS FOR MUTATIONS DETECTION Complete
2000 R21 CA088364 PAR-99-100 GASCOYNE, PETER RUSSELL CHARLES UNIVERSITY OF TEXAS MD ANDERSON CAN CTR INTEGRATED ISOLATION & MOLECULAR ANALYSIS OF TUMOR CELLS Complete
2002 R21 CA094441 PAR-99-100 HUANG, TIM H.-M. UNIVERSITY OF MISSOURI-COLUMBIA NOVEL TOOL FOR ANALYSIS OF PROMOTER HYPERMETHYLATION Complete
2005 R21 CA114149 RFA-CA-05-003 TUNG, CHING-HSUAN MASSACHUSETTS GENERAL HOSPITAL IMAGING TUMOR ASSOCIATED FIBROBLAST ACTIVATION PROTEIN Complete
2008 R21 CA126728 RFA-CA-07-035 MCCAWLEY, LISA JOY VANDERBILT UNIVERSITY PARALLEL CAPILLARY BIOREACTORS FOR LEUKOCYTE TRANSENDOTHELIAL MIGRATION ANALYSIS Complete
2011 R21 CA157395 RFA-CA-10-005 PARKER, LAURIE L. PURDUE UNIVERSITY LABEL-FREE, REAL-TIME DETECTION OF KINASE ACTIVITY IN VITRO AND IN SINGLE CELLS U Complete
2015 R21 CA196485 RFA-CA-14-003 SARAF, RAVI F UNIVERSITY OF NEBRASKA LINCOLN HIGH SPECIFICITY MICRORNA MICROARRAY ANALYSIS WITHOUT PCR FOR CANCER SCREENING AND RESEARCH Complete
1999 R43 CA081870 PAR-98-066 MILLER, JEFFREY E. IVS TECHNOLOGIES, LLC NEW METHOD FOR THE SYNTHESIS OF CDNA FROM CANCER CELLS Complete
2001 R43 CA092796 PAR-99-101 SHEN, SHANXIANG PROTIVERIS, INC. MICROCANTILEVER ARRAY DEVICE FOR PROTEIN PROFILING Complete
2004 R42 CA084688 PAR-01-105 SKIPPER, PAUL L NEWTON SCIENTIFIC, INC. TRITUM AMS ANALYSIS OF CANCER BIOMARKERS Complete
2007 R33 CA125520 RFA-CA-07-001 ROTHSTEIN, RODNEY J. COLUMBIA UNIVERSITY HEALTH SCIENCES USING SYNTHETIC DOSAGE LETHALITY TO SCREEN FOR NOVEL ANTI-TUMOR TARGETS Complete
2010 R21 CA143101 RFA-CA-09-008 KASSIS, AMIN I HARVARD MEDICAL SCHOOL NOVEL BLOOD ASSAY FOR LUNG CANCER DETECTION Complete
2014 R21 CA177457 RFA-CA-13-003 PETRITIS, KONSTANTINOS PHOENIX CHILDREN'S HOSPITAL PRESERVATION OF DRIED PLASMA SPOTS FOR DOWNSTREAM PROTEOMIC APPLICATIONS Complete
2017 R33 CA204704 RFA-CA-16-002 WANG, YINGXIAO UNIVERSITY OF CALIFORNIA, SAN DIEGO Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells Complete
2001 R33 CA081668 PAR-98-067 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON HIGH THROUGHPUT CALI FOR TARGET VALIDATION IN METASTASIS Complete
2003 R33 CA103068 PAR-01-106 COLLINS, COLIN C UNIVERSITY OF CALIFORNIA SAN FRANCISCO DEVELOPMENT OF ESP: STRUCTURAL & FUNCTIONAL ONCOGENOMICS Complete
2006 U43 CA122745 RFA-CA-06-006 BALGLEY, BRIAN M. CALIBRANT BIOSYSTEMS, INC. BREAST CANCER PROTEOMIC VIA LASER-FREE MICRODISSECTION AND GEMINI TECHNOLOGIES Complete
2009 R21 CA137706 RFA-CA-08-009 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY NANOTECHNOLOGY FOR ONE STEP CONCENTRATION AND PRESERVATION OF LABILE BIOMARKERS I Complete
2013 R33 CA174575 RFA-CA-12-003 JI, HANLEE P STANFORD UNIVERSITY OLIGONUCLEOTIDE-SELECTIVE SEQUENCING FOR INTEGRATED AND RAPID CANCER GENOME ANALY Complete
2016 R43 CA203675 PAR-13-327 KLUGE, JONATHAN AUGUST VAXESS TECHNOLOGIES, INC. SILK-BASED BLOOD SAMPLE STABILIZATION FOR PROSTATE CANCER DIAGNOSTICS Complete
2000 R41 CA083369 PAR-98-066 SWENBERG, JAMES A ENO RIVER LABS, LLC ULTRASENSITIVE METHODS FOR HUMAN DNA ADDUCT QUANTITATION Complete
2002 R43 CA096051 PAR-01-105 FENG, LI ECHELON BIOSCIENCES, INC. LIPID MICROARRAYS Complete
2006 R21 CA122673 RFA-CA-06-002 ZHANG, JIN JOHNS HOPKINS UNIVERSITY FLUORESCENT ACTIVITY SENSORS IN ANALYSIS OF ONCOGENIC P13K/AKT SIGNALING Complete
2008 R44 CA118785 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2012 R21 CA173390 RFA-CA-12-002 WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY PCR-FREE MULTIPLEXED DETECTION OF CIRCULATING MIRNA IN BLOOD Complete
2015 R43 CA199152 PAR-13-327 EASTBURN, DENNIS J MISSION BIO, INC. MOLECULAR CHARACTERIZATION OF CIRCULATING TUMOR CELLS WITH PCR-ACTIVATED CELL SORTING Complete
2021 R33 CA257878 RFA-CA-20-018 HANSEN, ANDERS SEJR MASSACHUSETTS INSTITUTE OF TECHNOLOGY Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer Active
2020 R21 CA240220 RFA-CA-19-019 ALEXANDRAKIS, GEORGIOS UNIVERSITY OF TEXAS ARLINGTON Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy Active
2019 R21 CA240199 RFA-CA-18-002 O'NEILL, RACHEL UNIVERSITY OF CONNECTICUT STORRS Development and Utilization of Splice-specific Antibodies Active
2021 R33 CA258016 RFA-CA-20-018 LIU, XUEFENG OHIO STATE UNIVERSITY Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics Active
2020 R33 CA247739 RFA-CA-19-020 MATRIX BHATNAGAR, PARIJAT SRI INTERNATIONAL T-cell Biofactories For Targeting Extracellular Matrix Active
2019 R21 CA240580 RFA-CA-18-002 MONTAGNA, CRISTINA ALBERT EINSTEIN COLLEGE OF MEDICINE Development of a high-resolution mapping platform for HPV DNA integration in premalignant lesions Active
2021 R44 CA261523 PAR-18-303 HUNG, PAUL JU-SUNG COMBINATI, INC. Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring Active
2020 R33 CA240181 RFA-CA-19-020 COOKS, ROBERT GRAHAM PURDUE UNIVERSITY Advanced Development Of Desorption Electrospray Ionization Mass Spectrometry For Intraoperative Molecular Diagnosis Of Brain Cancer Using Pathology Biopsies Active
2019 R33 CA225458 RFA-CA-18-003 KETTENBACH, ARMINJA NADINE DARTMOUTH COLLEGE Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics Active
2020 R21 CA251042 RFA-CA-19-021 GUPTA, GAUTAM UNIVERSITY OF LOUISVILLE Bio Cargos: Capture And Release Gels For Optimized Storage Of Cancer Biospecimens Active
2019 R33 CA225498 RFA-CA-18-003 CHEN, SIDI YALE UNIVERSITY Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers Active
2018 R33 CA228979 RFA-CA-17-011 SCHRUM, ADAM G UNIVERSITY OF MISSOURI-COLUMBIA Multiplex matrix ELISA for T cell protein-interaction networks in cancer Active
2020 R44 CA243990 PAR-18-303 GURARD-LEVIN, ZACHARY SAMDI TECH, INC. Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities Active
2019 R33 CA225549 RFA-CA-18-003 TAVANA, HOSSEIN UNIVERSITY OF AKRON A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery Active
2018 R33 CA229023 RFA-CA-17-011 TEWARI, MUNEESH (contact); WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations Active
2020 R21 CA246457 RFA-CA-19-019 HATTORI, TAKAMITSU NEW YORK UNIVERSITY SCHOOL OF MEDICINE Rational Generation Of High-performance Recombinant Antibodies To Post-translational Modifications Active
2019 R33 CA229042 RFA-CA-18-003 SCHNECK, JONATHAN P JOHNS HOPKINS UNIVERSITY A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells Active
2019 R33 CA229068 RFA-CA-18-003 SCHIAVINATO EBERLIN, LIVIA UNIVERSITY OF TEXAS, AUSTIN Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation Active

Pages



National Cancer Institute at the National Institutes of Health

 

NIH… Turning Discovery Into Health®